Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

minor correction:

Regeneron's 2 Day turnaround for Severe COVID-19 was meant to read as - ...Gilead's 2 Day turnaround for Severe COVID-19...

As it relates to Regeneron's 2 Day turnaround for Severe COVID-19 patients I believe is due to an ongoing collaborative relationship with the FDA and multiple clinical trials for remdesevir. Already having compiled and continuously updating data throughout the trials likely gave them the fastest track ever to an EUA.

Holla @ me

M$